Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 15.87 USD -2.16% Market Closed
Market Cap: 920.1m USD
Have any thoughts about
Cullinan Oncology Inc?
Write Note

Cullinan Oncology Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cullinan Oncology Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Cullinan Oncology Inc
NASDAQ:CGEM
Accrued Liabilities
$25.6m
CAGR 3-Years
77%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.2B
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$13.7B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.9B
CAGR 3-Years
26%
CAGR 5-Years
22%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Cullinan Oncology Inc's Accrued Liabilities?
Accrued Liabilities
25.6m USD

Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Accrued Liabilities amounts to 25.6m USD.

What is Cullinan Oncology Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
91%

Over the last year, the Accrued Liabilities growth was 67%. The average annual Accrued Liabilities growth rates for Cullinan Oncology Inc have been 77% over the past three years , 91% over the past five years .

Back to Top